These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1173537)

  • 1. Proceedings: Changes of pharmacokinetic parameters of new antiinflammatory drugs influenced by drug interaction.
    Zathurecký L; Szelepcsényiová A; Bruncková E; Masaryková V; Hajnovic F
    Acta Pharm Suec; 1974 Dec; 11(6):654-5. PubMed ID: 1173537
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of certain drugs in the domesticated goat.
    Boulos BM; Jenkins WL; Davis LE
    Am J Vet Res; 1972 May; 33(5):943-52. PubMed ID: 5023053
    [No Abstract]   [Full Text] [Related]  

  • 3. [The tissue cage in dogs--a pharmacologic model for the representation of plasma and tissue kinetics].
    Scherkl R; Hashem A; Frey HH
    Dtsch Tierarztl Wochenschr; 1996 May; 103(5):174-7. PubMed ID: 8964239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Species specific difference in binding to plasma proteins].
    Kurz H; Friemel G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):35-6. PubMed ID: 4231849
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interaction of phenylbutazone and tolbutamide in man].
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Orv Hetil; 1979 Nov; 120(47):2843-4. PubMed ID: 394087
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Pharmacokinetic analysis of the dicumarol-tolbutamide interaction in man.
    Jähnchen E; Gilfrich HJ; Groth U; Meinertz T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R88. PubMed ID: 49859
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of protein concentration on the binding of drugs to human serum albumin--I. Sulfadiazine, salicylate and phenylbutazone.
    Boobis SW; Chignell CF
    Biochem Pharmacol; 1979 Mar; 28(6):751-6. PubMed ID: 454474
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of phenylbutazone and tolbutamide in man.
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lead exposure on plasma phenylbutazone levels in rats.
    Basu N; Kulsreshtha T
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):61-2. PubMed ID: 8132249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition between salicylate and other drugs in binding to human serum protein in vitro.
    Muirden KD; Deutschman P; Phillips M
    Aust N Z J Med; 1974 Apr; 4(2):149-53. PubMed ID: 4528482
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of acidosis and alkalosis on the binding of drugs to plasma proteins].
    Kurz H; Mohr E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):164. PubMed ID: 4239201
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
    Melzacka M
    Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal model for theophylline--cimetidine drug interaction.
    Ritschel WA; Banerjee PS; Cacini W; Hassan M; Pesce AJ
    Methods Find Exp Clin Pharmacol; 1985 Dec; 7(12):627-9. PubMed ID: 3831635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic bases of the monitoring of antiepileptic drugs].
    Marino A; Pisanti N
    Clin Ter; 1984 Jul; 110(2):103-10. PubMed ID: 6237850
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic characteristics for extent of absorption and clearance in drug/drug interaction studies.
    Schall R; Hundt HK; Luus HG
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):633-7. PubMed ID: 7881699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of product inhibition on elimination kinetics of ethoxybenzamide in rabbits. Analysis by physiological pharmacokinetic model.
    Lin JH; Sugiyama Y; Hanano M; Awazu S
    Drug Metab Dispos; 1984; 12(2):253-6. PubMed ID: 6144493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic aspects of the effects and interactions of various neuro- and psychotropic drugs].
    Melzacka M
    Postepy Hig Med Dosw; 1985; 39(6):581-611. PubMed ID: 2873567
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kidney and drugs - urinary lithiasis. Pharmacokinetic glossary].
    Balant L
    Rev Med Suisse Romande; 1980 Nov; 100(11):949-56. PubMed ID: 7466067
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
    Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.